Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
19:13
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

54th ERA-EDTA Congress

 

3rd-6th June 2017 Madrid
FAQs
   
Discussion forum - 54th ERA-EDTA Congress
    Topic - Dialysis - Bone disease

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
 

Poster: 668
Visits: 10
Title: 30 MONTHS-EXPERIENCE ON DENOSUMAB IN OSTEOPOROTIC HEMODIALYSED PATIENTS
Authors: Alessandra Moioli , A. Moioli, C. Fofi, S. Barberi, G. Fioroni, L. Barbato, G.Argento, M. Tayefeh Jafari, G. Punzo, P. Menč and F. Festuccia.
Centre: SapienzaUniversity of Rome

You must be registered to reply or comment.

30 MONTHS-EXPERIENCE ON DENOSUMAB IN OSTEOPOROTIC HEMODIALYSED PATIENTS

M. CARMEN GORDEJO
Thread initiator
Subspeciality
Reg: 9/12/2014 5:52:00 PM

Comment# 1

In elderly subjects, renal insufficiency and osteoporosis often coexist with high risk of fracture and elevated socio-economic burden. Nowadays a large number of effective anti-osteoporotic drugs are available but generally they are contraindicated in patient with chronic kidney disease (CKD) because of their progressive accumulation.Denosumab (DN), antiRANK-L monoclonal antibody, instead does not require dose adjustments with different degrees of renal impairment so it can be a valid treatment in osteoporotic patient with CKD. We describe our experience in use of DN in osteoporotic, hemodialysed patients; limited data of this particular setting are available in literature.

Comment added on 5/25/2017 12:32:00 AM 
     
You must be registered to reply or comment.



Most viewed poster for this congress
Poster: 9
Visits: 267
Title: Report on dialysis and kidney transplantation in Serbia 2011-2014. Compare to others
Authors: Simic Ogrizovic Sanja ,
Centre: Serbian society of nephrology

Poster most viewed in this topic
Poster: 666
Visits: 47
Title: SNF472 A NOVEL INHIBITOR OF VASCULAR CALCIFICATION COULD BE ADMINISTERED DURING HEMODIALYSIS TO ATTAIN POTENTIALLY THERAPEUTIC PHYTATE LEVELS
Authors: Miguel Ferrer , Joan Perelló, Miquel Gómez, Miguel D. Ferrer, Néstor Y. Rodríguez, Carolina Salcedo, Juan M. Buades, Maria M. Pérez, Eva Martín, Francesc Maduell
Centre: Laboratoris Sanifit


 




PosterSessionOnline
Logo Draft
 
Logo Cert